These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2482771)

  • 1. BPH epidemiology and risk factors.
    Ekman P
    Prostate Suppl; 1989; 2():23-31. PubMed ID: 2482771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology, epidemiology, and natural history of benign prostatic hyperplasia.
    Bushman W
    Urol Clin North Am; 2009 Nov; 36(4):403-15, v. PubMed ID: 19942041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology and natural course of benign prostatic hyperplasia].
    Blom JH; Schröder FH
    Urologe A; 1992 May; 31(3):129-34. PubMed ID: 1377429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etiology and disease process of benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Prostate Suppl; 1989; 2():33-50. PubMed ID: 2482772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
    Boyle P
    Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
    Oesterling JE
    Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia.
    Fritschi L; Glass DC; Tabrizi JS; Leavy JE; Ambrosini GL
    Occup Environ Med; 2007 Jan; 64(1):60-5. PubMed ID: 17018583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed.
    Boyle P; McGinn R; Maisonneuve P; La Vecchia C
    Eur Urol; 1991; 20 Suppl 1():3-10. PubMed ID: 1722158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.
    Meigs JB; Mohr B; Barry MJ; Collins MM; McKinlay JB
    J Clin Epidemiol; 2001 Sep; 54(9):935-44. PubMed ID: 11520654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
    Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
    Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selenium status, dietary glucosinolate intake and serum glutathione S-transferase α activity on the risk of benign prostatic hyperplasia.
    Eichholzer M; Steinbrecher A; Kaaks R; Teucher B; Linseisen J; Rohrmann S
    BJU Int; 2012 Dec; 110(11 Pt C):E879-85. PubMed ID: 22882569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer.
    Montie JE; Pienta KJ
    Urology; 1994 Jun; 43(6):892-9. PubMed ID: 7515207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.
    Alcaraz A; Hammerer P; Tubaro A; Schröder FH; Castro R
    Eur Urol; 2009 Apr; 55(4):864-73. PubMed ID: 19027219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiopathogenesis of benign prostatic hypertrophy].
    Montanari E; Guarneri A; Dell'Orto P; Gelosa M
    Arch Ital Urol Androl; 1995 Feb; 67(1):7-12. PubMed ID: 7538393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.